tiprankstipranks
ABIONYX Pharma SA (FR:ABNX)
:ABNX
France Market
ABNX
ABIONYX Pharma SA
RESEARCH TOOLSreports

ABIONYX Pharma SA (ABNX) Financial Statements

5 Followers

ABIONYX Pharma SA Financial Overview

ABIONYX Pharma SA's market cap is currently €130.17M. The company's EPS TTM is €-0.092; its P/E ratio is -24.25; ABIONYX Pharma SA is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 4.06M€ 4.60M€ 4.64M€ 5.25M€ 675.00K
Gross Profit€ 376.00K€ 844.00K€ 618.00K€ 636.00K€ 259.00K
Operating Income€ -6.25M€ -5.57M€ -3.41M€ -4.11M€ -5.95M
EBITDA€ -5.70M€ -4.93M€ -4.84M€ -4.01M€ -7.42M
Net Income€ -5.55M€ -4.40M€ -3.52M€ -4.21M€ -5.82M
Balance Sheet
Cash & Short-Term Investments€ 3.52M€ 3.23M€ 4.10M€ 4.05M€ 7.93M
Total Assets€ 12.86M€ 13.45M€ 14.83M€ 15.82M€ 21.83M
Total Debt€ 3.81M€ 3.10M€ 3.39M€ 4.01M€ 4.96M
Net Debt€ 284.00K€ -137.00K€ -714.00K€ -33.00K€ -2.98M
Total Liabilities€ 8.60M€ 6.03M€ 6.91M€ 8.65M€ 11.15M
Stockholders' Equity€ 4.26M€ 7.42M€ 7.92M€ 7.17M€ 10.68M
Cash Flow
Free Cash Flow€ -3.17M€ -3.60M€ -3.83M€ -3.53M€ -6.86M
Operating Cash Flow€ -2.93M€ -3.60M€ -3.70M€ -3.36M€ -6.69M
Investing Cash Flow€ -205.00K€ -100.00K€ -130.00K€ -175.00K€ 1.34M
Financing Cash Flow€ 3.42M€ 2.80M€ 3.89M€ -194.00K€ 3.97M
Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

Income Statement >

ABIONYX Pharma SA Debt to Assets

Balance Sheet >

ABIONYX Pharma SA Cash Flow

Cash Flow >

ABIONYX Pharma SA Forecast EPS vs Actual EPS

Earnings >